BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang Y, Guo J, Huang L. Tackling TAMs for Cancer Immunotherapy: It's Nano Time. Trends Pharmacol Sci 2020;41:701-14. [PMID: 32946772 DOI: 10.1016/j.tips.2020.08.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Fan J, Gao Y, Huang S, Huang D, Li J, Wang X, Santos HA, Shen P, Xia B. Porous Silicon Nanocarriers Boost the Immunomodulation of Mitochondria-Targeted Bovine Serum Albumins on Macrophage Polarization. ACS Nano 2023. [PMID: 36598186 DOI: 10.1021/acsnano.2c07439] [Reference Citation Analysis]
2 Edavettal S, Cejudo-Martin P, Dasgupta B, Yang D, Buschman MD, Domingo D, Van Kolen K, Jaiprasat P, Gordon R, Schutsky K, Geist B, Taylor N, Soubrane CH, Van Der Helm E, LaCombe A, Ainekulu Z, Lacy E, Aligo J, Ho J, He Y, Lebowitz PF, Patterson JT, Scheer JM, Singh S. Enhanced delivery of antibodies across the blood-brain barrier via TEMs with inherent receptor-mediated phagocytosis. Med (N Y) 2022;3:860-882.e15. [PMID: 36257298 DOI: 10.1016/j.medj.2022.09.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhao J, Dong Y, Zhang Y, Wang J, Wang Z. Biophysical heterogeneity of myeloid-derived microenvironment to regulate resistance to cancer immunotherapy. Adv Drug Deliv Rev 2022;191:114585. [PMID: 36273512 DOI: 10.1016/j.addr.2022.114585] [Reference Citation Analysis]
4 Ni Z, Yu H, Wang L, Huang Y, Lu H, Zhou H, Liu Q. Multistage ROS-Responsive and Natural Polyphenol-Driven Prodrug Hydrogels for Diabetic Wound Healing. ACS Appl Mater Interfaces 2022. [DOI: 10.1021/acsami.2c15686] [Reference Citation Analysis]
5 Baharom F, Ramirez-Valdez RA, Khalilnezhad A, Khalilnezhad S, Dillon M, Hermans D, Fussell S, Tobin KKS, Dutertre CA, Lynn GM, Müller S, Ginhoux F, Ishizuka AS, Seder RA. Systemic vaccination induces CD8(+) T cells and remodels the tumor microenvironment. Cell 2022;185:4317-4332.e15. [PMID: 36302380 DOI: 10.1016/j.cell.2022.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Filiberti S, Russo M, Lonardi S, Bugatti M, Vermi W, Tournier C, Giurisato E. Self-Renewal of Macrophages: Tumor-Released Factors and Signaling Pathways. Biomedicines 2022;10:2709. [DOI: 10.3390/biomedicines10112709] [Reference Citation Analysis]
7 Lu Y, Zhao M, Peng Y, He S, Zhu X, Hu C, Xia G, Zuo T, Zhang X, Yun Y, Zhang W, Shen X. A physicochemical double-cross-linked gelatin hydrogel with enhanced antibacterial and anti-inflammatory capabilities for improving wound healing. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01634-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Kuninty PR, Binnemars-Postma K, Jarray A, Pednekar KP, Heinrich MA, Pijffers HJ, Ten Hoopen H, Storm G, van Hoogevest P, den Otter WK, Prakash J. Cancer immune therapy using engineered ‛tail-flipping' nanoliposomes targeting alternatively activated macrophages. Nat Commun 2022;13:4548. [PMID: 35927238 DOI: 10.1038/s41467-022-32091-9] [Reference Citation Analysis]
9 Lafuente-Gómez N, Wang S, Fontana F, Dhanjani M, García-Soriano D, Correia A, Castellanos M, Rodriguez Diaz C, Salas G, Santos HA, Somoza Á. Synergistic immunomodulatory effect in macrophages mediated by magnetic nanoparticles modified with miRNAs. Nanoscale 2022. [PMID: 35904896 DOI: 10.1039/d2nr01767a] [Reference Citation Analysis]
10 Chen G, Yang F, Fan S, Jin H, Liao K, Li X, Liu G, Liang J, Zhang J, Xu J, Pi J. Immunomodulatory roles of selenium nanoparticles: Novel arts for potential immunotherapy strategy development. Front Immunol 2022;13:956181. [DOI: 10.3389/fimmu.2022.956181] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Garmaroudi GA, Karimi F, Naeini LG, Kokabian P, Givtaj N, Rehman MU. Therapeutic Efficacy of Oncolytic Viruses in Fighting Cancer: Recent Advances and Perspective. Oxidative Medicine and Cellular Longevity 2022;2022:1-14. [DOI: 10.1155/2022/3142306] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Wang X, Xu Y, Sun Q, Zhou X, Ma W, Wu J, Zhuang J, Sun C. New insights from the single-cell level: Tumor associated macrophages heterogeneity and personalized therapy. Biomed Pharmacother 2022;153:113343. [PMID: 35785706 DOI: 10.1016/j.biopha.2022.113343] [Reference Citation Analysis]
13 Gao J, Liang Y, Wang L. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy. Front Immunol 2022;13:888713. [DOI: 10.3389/fimmu.2022.888713] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 Deng K, Yang D, Zhou Y. Nanotechnology-Based siRNA Delivery Systems to Overcome Tumor Immune Evasion in Cancer Immunotherapy. Pharmaceutics 2022;14:1344. [DOI: 10.3390/pharmaceutics14071344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Donoso-Meneses D, Figueroa-Valdés AI, Georges N, Tobar HE, Alcayaga-Miranda F. Turning adversity into opportunity: Small extracellular vesicles as nanocarriers for tumor-associated macrophages re-education. Bioeng Transl Med 2023;8:e10349. [PMID: 36684102 DOI: 10.1002/btm2.10349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Nadukkandy AS, Ganjoo E, Singh A, Dinesh Kumar L. Tracing New Landscapes in the Arena of Nanoparticle-Based Cancer Immunotherapy. Front Nanotechnol 2022;4:911063. [DOI: 10.3389/fnano.2022.911063] [Reference Citation Analysis]
17 Song Y, Bugada L, Li R, Hu H, Zhang L, Li C, Yuan H, Rajanayake KK, Truchan NA, Wen F, Gao W, Sun D. Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice. Sci Transl Med 2022;14:eabl3649. [PMID: 35507675 DOI: 10.1126/scitranslmed.abl3649] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
18 Yan H, Shi J, Dai Y, Li X, Wu Y, Zhang J, Gu Z, Zhang C, Leng J. Technique integration of single-cell RNA sequencing with spatially resolved transcriptomics in the tumor microenvironment. Cancer Cell Int 2022;22:155. [PMID: 35440049 DOI: 10.1186/s12935-022-02580-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Li T, Song R, Sun F, Saeed M, Guo X, Ye J, Chen F, Hou B, Zhu Q, Wang Y, Xie C, Tang L, Xu Z, Xu H, Yu H. Bioinspired magnetic nanocomplexes amplifying STING activation of tumor-associated macrophages to potentiate cancer immunotherapy. Nano Today 2022;43:101400. [DOI: 10.1016/j.nantod.2022.101400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Wang M, Hu Q, Huang J, Zhao X, Shao S, Zhang F, Yao Z, Ping Y, Liang T. Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy. J Nanobiotechnology 2022;20:85. [PMID: 35177078 DOI: 10.1186/s12951-022-01282-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Moradinasab S, Pourbagheri-Sigaroodi A, Ghaffari SH, Bashash D. Targeting macrophage-mediated tumor cell phagocytosis: An overview of phagocytosis checkpoints blockade, nanomedicine intervention, and engineered CAR-macrophage therapy. Int Immunopharmacol 2021;103:108499. [PMID: 34972068 DOI: 10.1016/j.intimp.2021.108499] [Reference Citation Analysis]
22 Shi L, Gu H. Emerging Nanoparticle Strategies for Modulating Tumor-Associated Macrophage Polarization. Biomolecules 2021;11:1912. [PMID: 34944555 DOI: 10.3390/biom11121912] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Huang X, Cao J, Zu X. Tumor-associated macrophages: An important player in breast cancer progression. Thorac Cancer 2021. [PMID: 34914196 DOI: 10.1111/1759-7714.14268] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Tian H, Lin L, Ba Z, Xue F, Li Y, Zeng W. Nanotechnology combining photoacoustic kinetics and chemical kinetics for thrombosis diagnosis and treatment. Chinese Chemical Letters 2021;32:3665-74. [DOI: 10.1016/j.cclet.2021.05.070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Ravi Kiran AVVV, Kusuma Kumari G, Krishnamurthy PT, Khaydarov RR. Tumor microenvironment and nanotherapeutics: intruding the tumor fort. Biomater Sci 2021;9:7667-704. [PMID: 34673853 DOI: 10.1039/d1bm01127h] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
26 Yang H, Yu Z, Ji S, Huo Q, Yan J, Gao Y, Niu Y, Xu M, Liu Y. Targeting bone microenvironments for treatment and early detection of cancer bone metastatic niches. J Control Release 2021:S0168-3659(21)00597-6. [PMID: 34748870 DOI: 10.1016/j.jconrel.2021.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Guo N, Ni K, Luo T, Lan G, Arina A, Xu Z, Mao J, Weichselbaum RR, Spiotto M, Lin W. Reprogramming of Neutrophils as Non-canonical Antigen Presenting Cells by Radiotherapy-Radiodynamic Therapy to Facilitate Immune-Mediated Tumor Regression. ACS Nano 2021. [PMID: 34709030 DOI: 10.1021/acsnano.1c04363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
28 He Y, de Araújo Júnior RF, Cruz LJ, Eich C. Functionalized Nanoparticles Targeting Tumor-Associated Macrophages as Cancer Therapy. Pharmaceutics 2021;13:1670. [PMID: 34683963 DOI: 10.3390/pharmaceutics13101670] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
29 Yang H, Song L, Sun B, Chu D, Yang L, Li M, Li H, Dai Y, Yu Z, Guo J. Modulation of macrophages by a paeoniflorin-loaded hyaluronic acid-based hydrogel promotes diabetic wound healing. Mater Today Bio 2021;12:100139. [PMID: 34632363 DOI: 10.1016/j.mtbio.2021.100139] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
30 Chamseddine AN, Assi T, Mir O, Chouaib S. Modulating tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors: A TAM-pting approach. Pharmacol Ther 2021;:107986. [PMID: 34481812 DOI: 10.1016/j.pharmthera.2021.107986] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
31 Poh AR, Ernst M. Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges. Cancers (Basel) 2021;13:2860. [PMID: 34201127 DOI: 10.3390/cancers13122860] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
32 Yan S, Wan G. Tumor-associated macrophages in immunotherapy. FEBS J 2021;288:6174-86. [PMID: 33492779 DOI: 10.1111/febs.15726] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
33 Yang S, Liu Q, Liao Q. Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Origin, Polarization, Function, and Reprogramming. Front Cell Dev Biol 2020;8:607209. [PMID: 33505964 DOI: 10.3389/fcell.2020.607209] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 22.5] [Reference Citation Analysis]
34 Guo J, Yu Z, Sun D, Zou Y, Liu Y, Huang L. Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma. Mol Cancer 2021;20:10. [PMID: 33407548 DOI: 10.1186/s12943-020-01297-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
35 Sun D, Zhang J, Wang L, Yu Z, O'Driscoll CM, Guo J. Nanodelivery of immunogenic cell death-inducers for cancer immunotherapy. Drug Discov Today 2021;26:651-62. [PMID: 33278602 DOI: 10.1016/j.drudis.2020.11.029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]